info Request information

Since 2010 Luperini Group is a consolidated, dynamic and organized structure to interface with the pharmaceutical industry and other important sectors of industrial production.

Made in excellence made in Luperini

The three brands Luperini Tailored Pharma Machinery, Luperini Qualified Pharma Service and Luperini Qualified Tech & Service operate on a shared ground made of technological know-how, strong innovative drive, research of the highest quality of product and service, willingness to customize solutions.

Group Numbers

10+

Years of experience

3

Companies

100+

People

Luperini Brands dedicated to the pharma industry capitalize on the historical competence of a team with strong experience in this sector.

logo Luperini Tailored Pharma Machinery

Luperini – Tailored Pharma Machinery

The Tailored Pharma Machinery proposes customized technologies with great affordability and accuracy.

Find out more
logo Luperini Qualified Pharma Service

Luperini Qualified Pharma Service

Luperini Qualified Pharma Service gives a complete range of excellent services: revamping and validation of existing machines and installations, spare parts and consulting, as well as ordinary and extraordinary maintenance.

Find out more

Luperini Qualified Tech & Service offers an articulated service activity for the integration, maintenance and installation of production plants for different industrial sectors, among which the Tissue one stands out.

logo Luperini Qualified Tech Service

Luperini – Qualified Tech Service

Thanks to a facility of 5000 sqm, Luperini Qualified Tech & Service is able to offer customers a highly qualified service of pre-assembly of plants as well as carry out inspections and tests to secure the customers’ investment.

Find out more

Luperini Production issues its first Convertible bond with SICI SGR

Comunicato Luperini

Lucca, March 7th, 2022 – LUPERINI PRODUCTION S.p.A. shareholders, opens with satisfaction to the entry of the fund Rilancio e Sviluppo managed by SICI, an asset management company focused on central Italy, which counts more than 90 investments.

LUPERINI PRODUCTION operates successfully through the brands LUPERINI GROUP, LUPERINI PHARMA and LUPERINI TECH, in the production sectors of machines and plants for the pharmaceutical industry and industrial assembly. This operation represents an important step in strengthening the Company’s development strategy in the various national and international reference markets, on which it operates in synergy with its partner ALCI GROUP, a well-established Group in the world of Industrial Automation based in Ascoli Piceno.

The bond, for a total amount of € 1.0 mln, will be subscribed by SICI in several tranches, is guaranteed by the Guarantee Fund for SMEs and will be converted upon achievement of certain industrial and development objectives.

The Company has appointed the new Board of Directors in the persons of Massimo Lungone, President and CEO, Marco Luperini, Technical Director, Valerio Alessi, General Manager of ALCI Group and Francesco Castaldelli, Senior Investment manager of SICI.

The agreement has been finalized also thanks to the support of CUTAdvisory, a business consulting and advisory company based in Prato and with the legal assistance of Studio Ubertazzi in Milan.

Mr. Massimo Lungone, President and CEO of Luperini Production, formerly Sole Director of the company, commented: “In the last five years we have achieved an exciting constant average growth of 51%, and this agreement aims to support and further accelerate this trend. I am very pleased with the entry of SICI, which strategically reinforces our already high reputation in the market and makes the Company even more financially sound. The investment creates the basis for a new phase of development allowing us both to expand our position in the industrial assembly market and to seize the enormous growth potential in the pharmaceutical sector thanks to the planned investments in terms of operational structure, sales and marketing“.

On the other hand, Marco Luperini, Research & Development Technical Director, lists the important fields of application of the overall competences gained over decades and the potential represented by the applications in the Pharma and Tech area: “Luperini has been operating for years through a solid structure that interfaces with the pharmaceutical industry and other important sectors of industrial production such as the paper industry. We are determined to keep growing by acting on the levers of technological know-how, innovative drive, research of the highest product and service quality, flexibility and streamlining, strengthened by our natural predisposition towards customization, which represents an important added value for our customers“.

Conviction and determination to achieve the result of business and growth is also what testifies Eng.
Valerio Alessi, CEO of ALCI GROUP, the third pillar of the company structure: “This operation will allow us to expand and strengthen our common commercial network, exploring new geographical areas and penetrating even more in those areas where we are already active. This development will give greater emphasis to the advantages generated by the ALCI LUPERINI synergy“.

Mr. Vittorio Gabbanini, President of SICI, comments: “We are very pleased to contribute to the development of Luperini. We have confidence in the strategy of the Company and in its team, which has demonstrated to be able to reach important growth targets with determination, focusing on research, innovation and quality. We are convinced that the entry of SICI will bring further dynamism in the reference markets of the Company, within the Italian and international industrial panorama“.

S.I.C.I. SGR S.p.A. – Sviluppo Imprese Centro Italia (www.fondisici.it) is the independent Asset Management Company of Central Italy financial and banking system, authorized since 1999 by the Bank of Italy to manage alternative investment funds established in closed form and is registered at no. 21 of the FIA Register of Managers. SICI manages 5 funds in addition to its own resources amounting to approximately € 148 million, including the “Relaunch and Development” Fund, aimed at the development of unlisted SMEs in Central Italy through investments in equity, semi-equity and minibonds to support their development and strengthen their capital and financial structure. To date, SICI has completed over 90 investments in many sectors of the economy and has 35 active equity investments and financial instruments in its portfolio.

This site is registered on wpml.org as a development site.